Biopharmaceutical company Dyax Corp. (DYAX: Quote) Friday said Ivana Magovcevic-Liebisch, its Executive Vice President and Chief Operating Officer, is leaving the Company to pursue a senior management role at a multinational pharmaceutical company, effective March 29, 2013. Magovcevic-Liebisch, however, would continue to serve the Company as a consultant following her departure.
Gustav Christensen, President and Chief Executive Officer, said in a statement, “She has played an important role in building Dyax into a successful commercial company and has helped establish an internal organization that is well-equipped to advance the Company’s strategy moving forward.”
Click here to receive FREE breaking news email alerts for Dyax Corp and others in your portfolio
by RTT Staff Writer
For comments and feedback: editorial@rttnews.comBusiness News